C-Shift SA
The score of C-Shift shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -28 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
C-Shift's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 01 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
C-Shift's financial analysis
- Solvency11.7%sector median: 52.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of C-Shift
C-Shift's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0634.938.739
- VAT number
- BE0634938739
- Peppol
- Registered · 0208:0634938739 · as of 02 Nov 2026
- Legal form
- SA
- Incorporated
- 10 Aug 2015
- Registered office
- 9042 Ghent
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Manufacture of other chemical products n.e.c. (NACE 20590)
C-Shift (SA) has been based in Ghent since 2015, active in: manufacture of other chemical products n.e.c.. For 2025, it reports a net loss of €2.16m and equity of €30.2m; its revenue is not published. Its solvency stands at 11.7%, below the median of its sector (52.9%).
Companies similar to C-Shift
Companies in the same business, of comparable size and area, outside its group.
- Fujirebio Europe Manufacture of other chemical products n.e.c. Ghent · balance sheet €81.8m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- Fujifilm Electronic Materials (Europe) Manufacture of other chemical products n.e.c. Beveren-Kruibeke-Zwijndrecht · balance sheet €268.6m
- Ablynx Research and experimental development on natural sciences and engineering Ghent · balance sheet €417.3m
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
- Biowanze Manufacture of refined petroleum products and fossil fuel products Wanze · balance sheet €439.9m
- TotalEnergies Olefins Antwerp Manufacture of other organic basic chemicals Antwerp · balance sheet €346.4m
- Alco Energy Manufacture of other organic basic chemicals Watermael-Boitsfort · balance sheet €522.7m
Frequently asked questions about C-Shift
What is the revenue of C-Shift?
C-Shift files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of C-Shift?
In Belgium, the VAT number is the company number prefixed with BE: BE0634938739 for C-Shift, if the company is VAT-registered. Its company number (CBE) is 0634.938.739.
Where is the registered office of C-Shift?
According to the CBE register, the registered office of C-Shift is in 9042 Ghent.
What is the equity of C-Shift?
At the close of the 2025 financial year, the equity of C-Shift amounts to 30,167,277 €, a solvency of 11.7% of total assets.
Who manages C-Shift?
The register lists 7 active mandates at C-Shift. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of C-Shift
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →